Abstract
Natural Daylight Photodynamic Therapy (NDL-PDT) is an efficacious treatment of actinic keratosis. However, daylight introduces uncontrolled variability (e.g., cloud cover, temperature) that may influence the effectiveness. SmartPDT® is a CE-marked digital medical device for phototherapy management. Thanks to a validated satellite-based technology, it can support clinicians in accurately planning and then monitoring from remote the effective solar radiation doses received by a patient in real-time anywhere (e.g., at home). The relevant solar doses monitored for NDL-PDT are PpIX-effective and erythema-effective (sunburn risk).We present the current results of an observational, multicentre, prospective clinical study on the use of SmartPDT® in clinical practice for NDL-PDT which is ongoing in Spain.
Authors
T. Gracia-Cazaña, University Hospital Miguel Servet, Zaragoza, Spain
A. Navarro Bielsa, University Hospital Miguel Servet, Zaragoza, Spain
M. Almenara Blasco, University Hospital Miguel Servet, Zaragoza, Spain
O. Yélamos, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
P. Fonda, Hospital Central De La Defensa Gómez Ulla, Madrid, Spain
A. J. García-Malinis, Hospital Universitario San Jorge, Huesca, Spain
I. Martinez, University Hospital Miguel Servet, Zaragoza, Spain
R. C. Temple, siHealth Ltd, Harwell Campus, Oxfordshire, UK
E. Simeone, siHealth Ltd, Harwell Campus, Oxfordshire, UK
M. Morelli, siHealth Ltd, Harwell Campus, Oxfordshire, UK
Y. Gilaberte, University Hospital Miguel Servet, Zaragoza, Spain
